Together with SREBP-cleavage activating proteins (SCAP), they are crucial for maintaining cellular lipid homeostasis [36]; hence their aberrant activation is known to cause fatty liver disease, insulin resistance, obesity, and cancer development [37]. This evidence concerns the gene SCAP and cancer.